MariaDB Platform X5 Adds New Distributed SQL

REDWOOD CITY, Calif. and HELSINKI – July 16, 2020 – MariaDB® Corporation today announced the general availability of MariaDB Platform X5, a comprehensive open source database solution delivering the ultimate in versatility across workloads and scalability from a single database or data warehouse to millions of transactions per second. This major release introduces powerful upgrades … Continued

Read More

MariaDB Gives the Power of Analytics to Millions for Free

MariaDB Community Server 10.5 turns into analytics powerhouse with cloud-native storage REDWOOD CITY, Calif. and HELSINKI – June 24, 2020 – MariaDB® Corporation today announced the general availability of MariaDB Community Server 10.5, a major new release that brings high-performance analytics to the hands of millions using the popular open source database. In a push … Continued

Read More

Razer announces Kishi

Original Article from The Verge In October, Razer announced Junglecat, a mobile gamepad with two Nintendo Switch Joy-Con-like controllers that attached to either side of your phone, but it only worked with four Android phones and required that you put your phones in a special case when you used it. Today at CES, just a few … Continued

Read More

MariaDB SkySQL Adds ‘Power Tier’ for Enterprises That Demand Distinction

REDWOOD CITY, Calif. and HELSINKI – May 13, 2020 – MariaDB® Corporation today announced the immediate availability of MariaDB SkySQL Power, the first database-as-a-service (DBaaS) offering that lets enterprises customize options and configurations to fit their distinct requirements. Built on top of SkySQL’s Foundation, which delivers the complete MariaDB Platform experience in the cloud, Power … Continued

Read More

AIVITA Biomedical Presents Updates from Ongoing Ovarian Cancer and Glioblastoma Clinical Studies at 2020 AACR Virtual Annual Meeting

IRVINE, Calif.–(BUSINESS WIRE)– AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today that updates from ongoing clinical trials in ovarian cancer and glioblastoma were presented as part of the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting I. The presentation from Daniela Bota, MD, Ph.D., of the University … Continued

Read More

AIVITA Biomedical Raises $12.5 Million in Series B-2 Financing Round and Announces New Board of Directors Appointee

Leader of Series B-2 Financing Round Matthew Katz Joins AIVITA’s Board of Directors IRVINE, Calif., Feb. 25, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a biotechnology company (the “Company”) specializing in innovative stem cell applications, announced today the first closing of its $25 million Series B-2 preferred stock investment round. The first closing of $12.5 million was … Continued

Read More

Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical’s Phase 2 Clinical Trial

IRVINE, Calif., Aug. 14, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today updated clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA’s platform immunotherapy targeting tumor-initiating cells. Blood plasma biomarker analyses have identified a robust immune response and a decrease of tumor biomarkers in … Continued

Read More

Ablexis Announces Licensing of the AlivaMab Mouse to Five Prime Therapeutics

BURLINGAME, Calif., Sept. 14, 2017 (GLOBE NEWSWIRE) — Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a license agreement with Five Prime Therapeutics, Inc. (NASDAQ:FPRX). The non-exclusive license grants Five Prime rights to use the AlivaMab Mouse for antibody drug discovery and development. “Ablexis is … Continued

Read More

Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma

AlivaMab Mouse Emerging as Top Pharmas’ Next-Generation Antibody Drug Discovery Platform of Choice BURLINGAME, Calif.–(BUSINESS WIRE)– 2, 2016 – Ablexis, LLC announced today the expansion of the roster of licensees of its AlivaMab Mouse technology to include an additional top 15 pharmaceutical company. The AlivaMab Mouse is a unique, next-generation transgenic mouse platform for human … Continued

Read More

MariaDB selected as Database of the Year.

MariaDB has been selected as Database of the Year in the Members’ Choice awards at LinuxQuestions.org for the third year running. The LinuxQuestions.org forum is the largest Linux user forum online, hosting from 100,000 to a million visitors every month. In a resounding show of support, fans gave MariaDB 45.5% of the vote, more than … Continued

Read More